Inventiva Pharma

Inventiva is a clinical-stage biopharmaceutical company focused on developing oral small molecule therapies with expertise in fibrosis, oncology, and orphan diseases. The company primarily targets diseases with unmet medical needs, such as NASH and systemic sclerosis, or conditions where existing therapies are inadequate, such as lysosomal storage disorders.